Disclosures for "An Investigation of Myelin Streamline Decomposition of Brain Networks in the SYNERGY Trial"
-
Miss Bosticardo has nothing to disclose.
-
Dr. Lu has nothing to disclose.
-
Dr. Tagge has received personal compensation for serving as an employee of Biogen. Dr. Tagge has stock in Biogen. Dr. Tagge has received research support from MITACS. Dr. Tagge has received research support from NeuroRx.
-
Bing Zhu has received personal compensation for serving as an employee of Biogen. Bing Zhu has received stock or an ownership interest from Biogen.
-
Sabine Schaedelin has nothing to disclose.
-
-
Dr. Granziera has nothing to disclose.